406 related articles for article (PubMed ID: 19362452)
1. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
[TBL] [Abstract][Full Text] [Related]
2. [Molecular epidemiology of Stenotrophomonas maltophilia strains isolated from paediatric patients].
Köseoğlu O; Sener B; Gür D
Mikrobiyol Bul; 2004; 38(1-2):9-19. PubMed ID: 15293897
[TBL] [Abstract][Full Text] [Related]
3. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections.
Passerini de Rossi B; Calenda M; Vay C; Franco M
Rev Argent Microbiol; 2007; 39(4):204-12. PubMed ID: 18390153
[TBL] [Abstract][Full Text] [Related]
4. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
5.
Alcaraz E; Garcia C; Papalia M; Vay C; Friedman L; Passerini de Rossi B
J Med Microbiol; 2018 Jul; 67(7):992-1002. PubMed ID: 29799387
[No Abstract] [Full Text] [Related]
6. Influence of an extended incubation period on values of minimum inhibitory concentrations of antibiotics in Stenotrophomonas maltophilia clinical strains.
Hejnar P; Hamal P; Koukalová D
New Microbiol; 2000 Oct; 23(4):415-21. PubMed ID: 11061630
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
Di Bonaventura G; D'Antonio D; Catamo G; D'Ercole S; Piccolomini R
Chemotherapy; 2002 Jul; 48(3):134-7. PubMed ID: 12138329
[TBL] [Abstract][Full Text] [Related]
8. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes.
Tan CK; Liaw SJ; Yu CJ; Teng LJ; Hsueh PR
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):205-10. PubMed ID: 17950557
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.
Passerini de Rossi B; Feldman L; Pineda MS; Vay C; Franco M
J Med Microbiol; 2012 Sep; 61(Pt 9):1248-1253. PubMed ID: 22580911
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies.
Venditti M; Monaco M; Micozzi A; Tarasi A; Friedrich A; Martino P
Clin Microbiol Infect; 2001 Jan; 7(1):37-9. PubMed ID: 11284945
[No Abstract] [Full Text] [Related]
11. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
13. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
[TBL] [Abstract][Full Text] [Related]
14. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Wei C; Ni W; Cai X; Cui J
Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].
Tao CM; Li XC; Lü XJ; Li P; Yu RJ; Gao YY; Chen HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):91-3. PubMed ID: 14981826
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation.
Liaw SJ; Lee YL; Hsueh PR
Int J Antimicrob Agents; 2010 Feb; 35(2):126-30. PubMed ID: 19926255
[TBL] [Abstract][Full Text] [Related]
17. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.
Senol E
J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709
[TBL] [Abstract][Full Text] [Related]
18. In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae.
Louie A; Brown DL; Liu W; Kulawy RW; Deziel MR; Drusano GL
Antimicrob Agents Chemother; 2007 Nov; 51(11):3988-4000. PubMed ID: 17846144
[TBL] [Abstract][Full Text] [Related]
19. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones.
Rolston KV; Kontoyiannis DP; Yadegarynia D; Raad II
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):215-8. PubMed ID: 15766609
[TBL] [Abstract][Full Text] [Related]
20. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]